https://www.bioworld.com/articles/695866-biotheryx-and-incyte-collaborate-on-targeted-protein-degraders-for-novel-oncology-targets?v=preview
Biotheryx and Incyte collaborate on targeted protein degraders for novel oncology targets | BioWorld
Biotheryx Inc. has entered into a research collaboration and license agreement with Incyte Corp. to discover and develop targeted protein degraders for novel...
targeted protein degradersincytecollaboratenoveloncology
https://www.wehi.edu.au/business-development-and-ventures/success-stories/developing-targeted-protein-degraders-into-innovative-cancer-medicines/
Developing targeted protein degraders into innovative cancer medicines | WEHI
Jul 10, 2023 - A shared ambition to develop a new class of anti-cancer therapeutics has brought WEHI and Boehringer Ingelheim, a leading research-driven pharmaceutical...
targeted protein degraderscancer medicinesdevelopinginnovative